NCM
GOSS icon

Nantahala Capital Management’s Gossamer Bio GOSS Stock Holding History

Nantahala Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-672,856
Closed -$664K – 140
2024
Q3 		$664K Hold
672,856
– – 0.03% 120
2024
Q2 		$623K Hold
672,856
– – 0.04% 115
2024
Q1 		$794K Hold
672,856
– – 0.05% 106
2023
Q4 		$614K Sell
672,856
-5,416,615
-89% -$4M 0.04% 110
2023
Q3 		$5.07M Buy
+6,089,471
New +$7.02M 0.43% 54

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Nantahala Capital Management's GOSS Position: Q4 2024 in Review

Nantahala Capital Management sold out of Gossamer Bio (GOSS) in Q4 2024, closing a stake of 672,856 shares — an estimated $664K sold.

Nantahala Capital Management first reported a position in GOSS in Q3 2023 and held it in 5 quarters. The position peaked at $5.07M in Q3 2023. 105 funds tracked by Wall St. Rank hold GOSS as of Q4 2024.

  • Nantahala Capital Management reported no remaining Gossamer Bio position as of Q4 2024 after selling out during the quarter.
  • Nantahala Capital Management sold 672,856 Gossamer Bio shares in Q4 2024, an estimated $664K.
  • Nantahala Capital Management first reported a position in Gossamer Bio in Q3 2023 and held it in 5 quarters.
  • Nantahala Capital Management's Gossamer Bio position peaked at $5.07M in Q3 2023.
  • 105 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2024.

Based on Nantahala Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.